Frequently Asked Questions
Common questions clinicians and patients ask after using this tool — and after receiving these results.
What are the most common symptoms of Sjögren's syndrome? ▼
Dry eyes and dry mouth are the hallmark symptoms of Sjögren's syndrome, but the disease is far more than a dryness condition. Patients often describe gritty or burning eyes, needing water to swallow food, accelerated dental decay, and difficulty speaking for long periods. Fatigue — often severe and disproportionate — is one of the most disabling features. Joint pain, brain fog, and peripheral neuropathy are common. Parotid gland swelling (puffiness in front of the ears or under the jaw) on both sides is one of the most specific clinical features. Symptoms often predate diagnosis by 5–10 years.
What is the difference between primary and secondary Sjögren's? ▼
Primary Sjögren's syndrome occurs on its own, without another underlying autoimmune disease. Secondary Sjögren's refers to sicca features (dry eyes, dry mouth) occurring in the context of another autoimmune condition — most commonly rheumatoid arthritis (30%), SLE (20%), and systemic sclerosis. Both forms share similar symptoms and antibody profiles, but secondary Sjögren's management is guided by the primary disease. Anti-SSA (Ro) positivity is common in both forms. This calculator assesses features of primary Sjögren's.
What do anti-SSA and anti-SSB antibodies mean? ▼
Anti-SSA (Ro) and anti-SSB (La) are the signature antibodies of Sjögren's syndrome. Anti-SSA (Ro) is present in approximately 50–75% of primary Sjögren's patients and is the more sensitive of the two. Anti-SSB (La) is less common (~25–40%) but more specific. Both antibodies can also be found in SLE. An important clinical consequence: anti-SSA positivity in a pregnant woman significantly raises the risk of neonatal lupus and congenital heart block in the fetus, requiring fetal cardiac monitoring. A negative anti-SSA does not exclude Sjögren's — approximately 25–40% of patients are seronegative.
Is Sjögren's syndrome dangerous? ▼
For most patients, Sjögren's causes significant morbidity through dryness, fatigue, and neuropathy — but is not life-threatening. However, Sjögren's carries an approximately 15–20× increased risk of non-Hodgkin's B-cell lymphoma compared to the general population, particularly mucosa-associated lymphoid tissue (MALT) lymphoma. Risk factors for lymphoma include parotid gland enlargement, palpable purpura, cryoglobulinemia, low complement, and high-grade lymphocytic focus score on lip biopsy. Any new parotid swelling or unexplained lymphadenopathy in a Sjögren's patient warrants lymphoma surveillance.
Does Sjögren's cause fatigue? ▼
Yes — fatigue is one of the most prevalent and debilitating symptoms of Sjögren's syndrome, reported by 70–80% of patients and often rated as their most impactful symptom. The fatigue in Sjögren's is not fully explained by sicca symptoms alone and appears to have central and inflammatory components. It is not well-controlled by hydroxychloroquine in most patients, and there is no proven disease-modifying therapy specifically for Sjögren's fatigue. Evaluation should exclude contributing factors including anemia, thyroid disease, sleep apnea, and depression, all of which are more common in Sjögren's patients.
Can men get Sjögren's syndrome? ▼
Yes, though Sjögren's syndrome is predominantly a disease of middle-aged women with a female:male ratio of approximately 9:1. Men account for about 10% of Sjögren's patients. Men with Sjögren's tend to present later, are more likely to be seronegative (anti-SSA negative), and have a higher rate of extraglandular manifestations including peripheral neuropathy and renal tubular acidosis. The diagnosis is often delayed in men because dry eyes and dry mouth are less frequently attributed to autoimmune disease. Men with unexplained peripheral neuropathy and sicca features should be screened for Sjögren's.